| Identification | Back Directory | [Name]
Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-[(2-amino-2-methyl-1-oxopropyl)amino]-2,6-bis(1-methylethyl)phenyl ester (9CI) | [CAS]
199984-40-2 | [Synonyms]
ACAT-IN-9
Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-[(2-amino-2-methyl-1-oxopropyl)amino]-2,6-bis(1-methylethyl)phenyl ester (9CI) | [Molecular Formula]
C33H51N3O5S | [MOL File]
199984-40-2.mol | [Molecular Weight]
601.84 |
| Hazard Information | Back Directory | [Uses]
ACAT-IN-9 is an acyl-Coenzyme A:cholesterol acyltransferase (ACAT) inhibitor extracted from patent EP1236468A1, example 207. ACAT-IN-9 inhibits NF-κB mediated transcription[1]. | [References]
[1] Joseph Anthony Cornicelli, et al. Sulfonylaminocarbonyl derivatives for the treatment of nuclear factor-kappa B mediated diseases and disorders. EP1236468A1. |
|
|